IMDx was founded out of an underserved need in the industry: rapid and effective diagnostics to shrink the turnaround time between a patient presenting with an illness and a prescribed targeted treatment. As the IVD diagnostics space shifts from widely accepted, traditional culture methods, to highly sensitive and specific molecular methods, IMDx is uniquely positioned to make a difference in global healthcare. A privately held company based in Waltham, MA, IMDx employs experts from diverse backgrounds including financial, legal, quality, scientific, and medical, and is run in a unique manner such that all are involved in shaping products from concept stage to commercialization. IMDx has been named a Business Leader in Medical Diagnostics by Scientific American magazine within the Scientific American 50 and has been granted a North American Healthcare Innovation Award in molecular diagnostics by Frost & Sullivan. NOTE: This page is not intended to be used for filing product performance issues or complaints. Please consult product-specific package inserts to be directed to appropriate complaint handling personnel.